达普托米辛通过抑制炎症性细胞因子和NF-κB通路来缓解原诱导的关节炎
Yang Ye1, Yue Liang1, Lan Huang1
1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, No.17, 3rd Section of People's South Road, Chengdu, 610041, PR China.
International immunopharmacology
|November 21, 2024
概括
在类风湿性关节炎 (RA) 模型中,daptomycin (DAP) 通过减少关键的炎症标志物,显示出抗炎作用. 这项研究揭示了DAP.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学 是一个学科.
- 类风湿病学 类风湿病学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,具有复杂的病原性因素,包括免疫性炎症.
- 达普托米辛 (DAP) 是一种循环脂,以其强大的抗菌活性对抗格兰氏阳性细菌而闻名.
研究的目的:
- 在类风湿性关节炎 (RA) 的背景下调查达普托米辛 (DAP) 的潜在抗炎活性.
- 阐明DAP对RA的影响背后的分子药理机制.
主要方法:
- 在体外研究中使用脂聚糖激活的RAW 264.7巨细胞.
- 使用原诱导性关节炎 (CIA) 鼠标模型的体内研究.
- 评估炎症性细胞因子水平 (IL-1β,IL-6,TNF-α) 和p65酸化.
主要成果:
- DAP (10μg/mL) 抑制了激活巨细胞中IL-1β,IL-6和TNF-α的分泌,减少了细胞炎症.
- 在RAW 264.7细胞中,DAP暴露降低了p65 (p-p65) 的酸化.
- 在CIA小鼠中,静脉注射DAP (10 mg/kg/2d) 显著降低了关节炎症状,与降低的p-p65水平以及降低的血清IL-6,IL-1β和TNF-α相关.
结论:
- 在风湿性关节炎的体外和体外模型中,达普托米辛表现出显著的抗炎作用.
- 该研究揭示了DAP的新型免疫调节作用,表明了超越细菌感染的新临床应用的潜力.
- DAP的机制涉及抑制p65信号通路,为其在免疫相关疾病中使用提供药理基础.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K


